Attached files
EXHIBIT 32.2
CERTIFICATION PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)
In connection with the accompanying Annual Report of Avanir Pharmaceuticals, Inc. (the Company) on Form 10-K for the fiscal year ended September 30, 2014 (the Report), I, Christine G. Ocampo, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: December 10, 2014 | /s/ Christine G. Ocampo | |||||
Christine G. Ocampo | ||||||
Vice President, Finance | ||||||
[Principal Financial Officer] |